B of A Securities Maintains Neutral on AbbVie, Raises Price Target to $195
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has maintained a Neutral rating on AbbVie while raising the price target from $185 to $195.
October 18, 2024 | 5:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
B of A Securities has maintained a Neutral rating on AbbVie and increased the price target from $185 to $195, indicating a positive outlook on the stock's potential.
The increase in the price target from $185 to $195 suggests a positive outlook on AbbVie's stock performance. Although the rating remains Neutral, the raised target indicates potential for growth, which could positively influence investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100